Background: Ascites or pulmonary hypertension syndrome (PHS) is one of the significant problems in the poultry industry. Therefore, various studies have been conducted on its contributing factors. Objectives: This study aimed to investigate the role of vitamin E in reducing the mRNA levels of caspase-1 (CASP1), caspase-2 (CASP2), and caspase-3 (CASP3) genes involved in the apoptosis pathway. Methods: Ninety fast-growing 1-day-old chickens (Ross 308) were randomly assigned to three equal groups, including sham (basal diet), control (basal diet+1.5 mg/kg of triiodothyronine [T3]), and treatment group (basal diet+400 mg/kg of vitamin E+1.5 mg/kg of T3). To induce ascites, 1.5 mg/kg of T3 was added to basal diet from the seventh day to the end of the experiment. On the 21st and 49th days after rearing, 15 chicks from each group were randomly selected. The right ventricle/total ventricle weight ratio (RV/TV) and the expression levels of CASP1, CASP2, and CASP3 genes in the lung and right ventricle of all three groups of broiler chickens were measured and compared. Results: Although there was no significant difference between the three groups in terms of the RV/TV ratio on day 21 post-reared (P≥0.05), a significant decrease was detected in the vitamin E-receiving group compared to the control group with respect to the RV/TV ratio on day 49 post-reared (P<0.05). Also, vitamin E reduced the relative expression of CASP1, CASP2, and CASP3 at 49 days of age in the lung and heart tissues of broiler chickens with ascites (P<0.05). Conclusion: Based on the results of this study, it seems that vitamin E can reduce some apoptosis genes (CASP1, CASP2, and CASP3) associated with pulmonary hypertension in broilers.

Background: Avian influenza viruses (AIVs) including the subtype H9N2 cause considerable financial losses to poultry industries. Rapid and accurate diagnosis of avian influenza (AI) infection is important in control and eradication programs. OBJECTIVES: The aim of this study was to produce monoclonal antibodies (MAbs) specific for the nucleocapsid protein )NP (of AIV H9N2 subtype to improve diagnostic assays. METHODS: Recombinant NP protein was expressed in Escherichia coli and purified using amylose resin chromatography column and used as an antigen for mice immunization. Spleen cells of the immunized mice were fused with SP2/0 myeloma cells. Next, culture supernatants of primary hybridoma clones were screened by indirect ELISA. After three rounds of sub cloning, the reactivity of the MAbs with recombinant and natural antigens was assessed by Western blotting. RESULTS: Six MAbs showed specific binding to recombinant and natural NP from AIV H9N2 in Western blot analysis, enzyme-linked immunosorbent assay (ELISA) and immunofluorescence assay. Cross-reactivity with genetically non-related including Newcastle viruse (Paramyxoviridae family) was not detected. CONCLUSIONS: Based on the results, the MAbs generated in this study could be used for the development of rapid diagnostic assays for recognition of AIV.